PATTIES FOODS (PH4) - Total Liabilities
Based on the latest financial reports, PATTIES FOODS (PH4) has total liabilities worth €741.60 Million EUR (≈ $867.01 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore PATTIES FOODS cash flow conversion to assess how effectively this company generates cash.
PATTIES FOODS - Total Liabilities Trend (2020–2025)
This chart illustrates how PATTIES FOODS's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of PATTIES FOODS to evaluate the company's liquid asset resilience ratio.
PATTIES FOODS Competitors by Total Liabilities
The table below lists competitors of PATTIES FOODS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Beijing Urban Construction Investment & Development Co Ltd
SHG:600266
|
China | CN¥78.25 Billion |
|
Akzo Nobel India Limited
NSE:AKZOINDIA
|
India | Rs13.95 Billion |
|
Engineers India Limited
NSE:ENGINERSIN
|
India | Rs27.51 Billion |
|
Dampskibsselskabet Norden AS
CO:DNORD
|
Denmark | Dkr1.20 Billion |
|
Flight Centre Travel Group Ltd
AU:FLT
|
Australia | AU$3.47 Billion |
|
Nabors Industries Ltd.
NYSE:NBR
|
USA | $2.94 Billion |
|
Companhiade Eletricidade do Estado da Bahia - COELBA
SA:CEEB3
|
Brazil | R$24.81 Billion |
|
Kelt Exploration Ltd.
TO:KEL
|
Canada | CA$477.39 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down PATTIES FOODS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PATTIES FOODS (PH4) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.18 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PATTIES FOODS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PATTIES FOODS (2020–2025)
The table below shows the annual total liabilities of PATTIES FOODS from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €741.60 Million ≈ $867.01 Million |
-27.97% |
| 2024-12-31 | €1.03 Billion ≈ $1.20 Billion |
-14.57% |
| 2023-12-31 | €1.21 Billion ≈ $1.41 Billion |
+1.35% |
| 2022-12-31 | €1.19 Billion ≈ $1.39 Billion |
+11.71% |
| 2021-12-31 | €1.06 Billion ≈ $1.24 Billion |
+31.69% |
| 2020-12-31 | €808.29 Million ≈ $944.98 Million |
-- |
About PATTIES FOODS
CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junctio… Read more